
Roberto Velez
Supervisory Patent Examiner (ID: 2100, Phone: (571)272-8597 , Office: P/2662 )
| Most Active Art Unit | 2829 |
| Art Unit(s) | 2662, 3600, 2829, 2858 |
| Total Applications | 468 |
| Issued Applications | 291 |
| Pending Applications | 74 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16398745
[patent_doc_number] => 20200339603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
[patent_app_type] => utility
[patent_app_number] => 16/862442
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862442
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862442 | Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection | Apr 28, 2020 | Abandoned |
Array
(
[id] => 17733208
[patent_doc_number] => 20220218667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/605525
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605525 | DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND METHODS OF USE THEREOF | Apr 23, 2020 | Abandoned |
Array
(
[id] => 16397184
[patent_doc_number] => 20200338042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => USE OF DAPHNETIN IN TREATMENT OF AGE-RELATED COGNITIVE DECLINE
[patent_app_type] => utility
[patent_app_number] => 16/854910
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854910 | USE OF DAPHNETIN IN TREATMENT OF AGE-RELATED COGNITIVE DECLINE | Apr 21, 2020 | Abandoned |
Array
(
[id] => 18362222
[patent_doc_number] => 20230143813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Use of Ovatodiolide against SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 17/996226
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996226 | Use of Ovatodiolide against SARS-CoV-2 | Apr 16, 2020 | Issued |
Array
(
[id] => 16204698
[patent_doc_number] => 20200237688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE
[patent_app_type] => utility
[patent_app_number] => 16/846989
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846989 | VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE | Apr 12, 2020 | Abandoned |
Array
(
[id] => 17393551
[patent_doc_number] => 11242554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes
[patent_app_type] => utility
[patent_app_number] => 16/844223
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 32
[patent_no_of_words] => 17432
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844223 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | Apr 8, 2020 | Issued |
Array
(
[id] => 17731012
[patent_doc_number] => 11387414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Spirobifluorene compounds for organic electroluminescent devices
[patent_app_type] => utility
[patent_app_number] => 16/842522
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14517
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842522 | Spirobifluorene compounds for organic electroluminescent devices | Apr 6, 2020 | Issued |
Array
(
[id] => 17319341
[patent_doc_number] => 20210408391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => N HETEROCYCLIC PLANAR PHOTOCOUPLER OUTPUT MATERIAL AND METHOD OF PREPARING THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/762146
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762146
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762146 | N heterocyclic planar photocoupler output material and method of preparing thereof | Apr 1, 2020 | Issued |
Array
(
[id] => 16176847
[patent_doc_number] => 20200223815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/834267
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834267 | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | Mar 29, 2020 | Issued |
Array
(
[id] => 17119622
[patent_doc_number] => 11130744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Indenyl compounds, pharmaceutical compositions, and medical uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/834348
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 33
[patent_no_of_words] => 42233
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834348 | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | Mar 29, 2020 | Issued |
Array
(
[id] => 16348446
[patent_doc_number] => 20200313097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/831696
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831696 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | Mar 25, 2020 | Issued |
Array
(
[id] => 16190743
[patent_doc_number] => 20200231592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => SUBSTITUTED 2-(4-HETEROCYCLYLBENZYL)ISOINDOLIN-1-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1
[patent_app_type] => utility
[patent_app_number] => 16/823130
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 475
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823130 | SUBSTITUTED 2-(4-HETEROCYCLYLBENZYL)ISOINDOLIN-1-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 | Mar 17, 2020 | Abandoned |
Array
(
[id] => 16169418
[patent_doc_number] => 10710966
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-07-14
[patent_title] => Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/818863
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 29668
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818863
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818863 | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof | Mar 12, 2020 | Issued |
Array
(
[id] => 17604010
[patent_doc_number] => 11332481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Hole transporting material using dihydrophenazine as core and organic light emitting diode
[patent_app_type] => utility
[patent_app_number] => 16/652835
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2447
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652835 | Hole transporting material using dihydrophenazine as core and organic light emitting diode | Feb 13, 2020 | Issued |
Array
(
[id] => 16565164
[patent_doc_number] => 10890529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Duplex stabilizing fluorescence quenchers for nucleic acid probes
[patent_app_type] => utility
[patent_app_number] => 16/788588
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 32
[patent_no_of_words] => 23884
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788588
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788588 | Duplex stabilizing fluorescence quenchers for nucleic acid probes | Feb 11, 2020 | Issued |
Array
(
[id] => 19940297
[patent_doc_number] => 12312419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Hemiasterlin derivative having cysteine residue
[patent_app_type] => utility
[patent_app_number] => 17/429429
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29623
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 672
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429429 | Hemiasterlin derivative having cysteine residue | Feb 11, 2020 | Issued |
Array
(
[id] => 17603981
[patent_doc_number] => 11332452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Pesticidal compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/263928
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29563
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 369
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263928 | Pesticidal compositions and methods | Jan 29, 2020 | Issued |
Array
(
[id] => 17520449
[patent_doc_number] => 20220106298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/424413
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 354
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424413 | Bis(diazirine) derivatives as photo-crosslinker for treating corneal ectatic disorders | Jan 23, 2020 | Issued |
Array
(
[id] => 16686679
[patent_doc_number] => 20210069154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Treatment of Breast Cancer
[patent_app_type] => utility
[patent_app_number] => 16/749133
[patent_app_country] => US
[patent_app_date] => 2020-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16749133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/749133 | Treatment of Breast Cancer | Jan 21, 2020 | Abandoned |
Array
(
[id] => 16236645
[patent_doc_number] => 20200253879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/746399
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/746399 | Sustained release dosage forms for a JAK1 inhibitor | Jan 16, 2020 | Issued |